Search results for "Skin Disease"

showing 10 items of 104 documents

Positionspapier: Diagnostik und Therapie der Xerosis cutis.

2018

Hintergrund und rationale Die Xerosis cutis (Synonym: Xerodermie, trockene Haut, hydrolipidarme Haut) ist mit > 10 Millionen Betroffenen nicht nur eine der haufigsten dermatologischen Diagnosen in Deutschland, sondern auch Leitsymptom vieler dermatologischer, internistischer und neurologischer Erkrankungen. Trotz der medizinischen Relevanz der topischen Basistherapie fur die Xerosis cutis gibt es in Deutschland fur ihr Management bisher keinen wissenschaftlich belegten Diagnostik- und Therapiealgorithmus. ZIEL: Dieses Positionspapier vermittelt Arzten fachubergreifend einen an individuellen Symptomen orientierten, praxisnahen Leitfaden fur die Pravention, Diagnostik und Therapie der Xerosis…

Gynecology030207 dermatology & venereal diseases03 medical and health sciencesmedicine.medical_specialty0302 clinical medicineEvidence-Based Medicinebusiness.industry030220 oncology & carcinogenesismedicineHumansDermatologybusinessSkin DiseasesJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
researchProduct

Extrahepatic manifestations of hepatitis C virus infection.

2008

Hepatitis C virus may cause hepatic and extrahepatic diseases. Extrahepatic manifestations range from disorders for which a significant association with viral infection is supported by epidemiologic and pathogenetic data, to anecdotal observations without clear proof of causality. This article describes the diagnosis and treatment of these diseases.

Hepatologybusiness.industryHepatitis C virusHepacivirusmedicine.disease_causeViral infectionHepatitis CSkin DiseasesLymphoproliferative DisordersImmunologyMedicineHumansKidney DiseasesMusculoskeletal DiseasesNervous System DiseasesbusinessClinics in liver disease
researchProduct

Inhibition of murine IgE and immediate cutaneous hypersensitivity responses to ovalbumin by the immunomodulatory agent leflunomide

1999

SUMMARYLeflunomide has been identified as an immunoregulatory and anti-inflammatory compound. Allergic disease is characterized by elevated serum IgE levels, production of allergen-specific IgE and the release of inflammatory mediators from mast cells and granulocytes. Here we demonstrate, using an in vivo murine model, the ability of leflunomide to down-regulate levels of total and allergen-specific serum IgE production. Mice receiving leflunomide (45 mg/kg) orally at the time of primary immunization with ovalbumin adsorbed to aluminium hydroxide adjuvant, showed a reduction in total serum IgE levels of 95%, 41% and 32% following primary, secondary and tertiary immunizations, respectively …

Hypersensitivity ImmediateOvalbuminT-LymphocytesImmunologyPopulationDown-RegulationImmunoglobulin ESkin DiseasesMiceAdjuvants ImmunologicmedicineImmunology and AllergyAnimalseducationInterleukin 5Leflunomideeducation.field_of_studyMice Inbred BALB CbiologyVaccinationOriginal ArticlesIsoxazolesAllergensImmunoglobulin EAdoptive TransferTransplantationOvalbuminImmunoglobulin class switchingImmunologyAntibody Formationbiology.proteinFemaleAntibodyInterleukin-5Immunologic MemoryLeflunomidemedicine.drug
researchProduct

Advances in antioxidant phytochemical for inflammatory skin diseases: mangiferin and naringin nanocarriers based lipids

2020

Chronic inflammatory skin diseases are the most common topical disorders and the fourth cause of global disability. Among all, psoriasis (PS) and atopic dermatitis (AD) are the most frequent chronic and recurrent inflammatory diseases of the skin. Atopic dermatitis has a strong Th2 factor while psoriasis is a disease driven by Th17. The actual treatment, which involve the combination of topical, systemic and biological therapy, is characterized by numerous adverse effects, which reduce patient compliance, lead to the limitation of long-term use and limit the therapeutic efficacy. Therefore, there is a great need for the continuous development of novel, effective and safe coadjuvant treatmen…

Inflammationnanoemulsionsin vitro studiesatopic dermatitisnaringinpsoriasis:CIENCIAS MÉDICAS [UNESCO]mangiferinTPA modelskin diseasesphospholipid vesiclesfibroblastsUNESCO::CIENCIAS MÉDICAShyaluronic acid
researchProduct

Nanotechnology for Natural Medicine: Formulation of Neem Oil Loaded Phospholipid Vesicles Modified with Argan Oil as a Strategy to Protect the Skin f…

2021

Neem oil, a plant-derived product rich in bioactives, has been incorporated in liposomes and hyalurosomes modified by adding argan oil and so called argan-liposomes and argan-hyaluro-somes. Argan oil has also been added to the vesicles because of its regenerative and protective effects on skin. In the light of this, vesicles were specifically tailored to protect the skin from oxidative stress and treat lesions. Argan-liposomes were the smallest vesicles (~113 nm); the addition of sodium hyaluronate led to an increase in vesicle size (~143 nm) but it significantly improved vesicle stability during storage. In vitro studies confirmed the free radical scavenging activity of formula-tions, irre…

Keratinocytes0301 basic medicineEstrèsliposomeskeratinocytesfood.ingredientHyalurosomesPhysiologyClinical BiochemistryArgan oil02 engineering and technologyRM1-950medicine.disease_causeStressBiochemistryArticle03 medical and health scienceschemistry.chemical_compoundfoodfibroblastsmedicineHydrogen peroxideMolecular BiologyLiposomeNeem oilOlis essencialsViscosityVesicleCell BiologyFibroblasts021001 nanoscience & nanotechnologyIn vitroSkin diseases030104 developmental biologychemistryMalalties de la pellskin diseasesOxidative stressEssences and essential oilsLiposomesviscosityBiophysicshyalurosomesTherapeutics. Pharmacology0210 nano-technologyWound healingOxidative stressAntioxidants
researchProduct

Characterization of disease-specific cellular abundance profiles of chronic inflammatory skin conditions from deconvolution of biopsy samples

2019

Background Psoriasis and atopic dermatitis are two inflammatory skin diseases with a high prevalence and a significant burden on the patients. Underlying molecular mechanisms include chronic inflammation and abnormal proliferation. However, the cell types contributing to these molecular mechanisms are much less understood. Recently, deconvolution methodologies have allowed the digital quantification of cell types in bulk tissue based on mRNA expression data from biopsies. Using these methods to study the cellular composition of the skin enables the rapid enumeration of multiple cell types, providing insight into the numerical changes of cell types associated with chronic inflammatory skin c…

Keratinocytes0301 basic medicinePathologyMicroarraysBiopsyPATHOGENESISTranscriptome0302 clinical medicineDatabases GeneticLeukocytesATOPIC-DERMATITISGenetics (clinical)SkinPSORIASISmedicine.diagnostic_testintegumentary systemAtopic dermatitisDermismedicine.anatomical_structureDIFFERENTIATION030220 oncology & carcinogenesisChronic inflammatory skin diseasesResearch ArticleEXPRESSIONlcsh:Internal medicinemedicine.medical_specialtyCell typeGENESlcsh:QH426-470BiologyDENDRITIC CELLSDermatitis AtopicFlow cytometryMECHANISMS03 medical and health sciencesDermisPsoriasisBiopsyGeneticsmedicineHumanslcsh:RC31-1245SIGNATURESInflammationIDENTIFICATIONReproducibility of Resultsmedicine.diseaselcsh:Genetics030104 developmental biologyGene Expression RegulationChronic DiseaseSkin biopsyGene expressionEpidermis
researchProduct

Topical Application of Glycolipids from Isochrysis galbana Prevents Epidermal Hyperplasia in Mice

2017

Chronic inflammatory skin diseases such as psoriasis have a significant impact on society. Currently, the major topical treatments have many side effects, making their continued use in patients difficult. Microalgae have emerged as a source of bio-active molecules such as glycolipids with potent anti-inflammatory properties. We aimed to investigate the effects of a glycolipid (MGMG-A) and a glycolipid fraction (MGDG) obtained from the microalga Isochrysis galbana on a TPA-induced epidermal hyperplasia murine model. In a first set of experiments, we examined the preventive effects of MGMG-A and MGDG dissolved in acetone on TPA-induced hyperplasia model in mice. In a second step, we performed…

Keratinocytes0301 basic medicineglycolipidsAdministration Topicalmedicine.medical_treatmentPharmaceutical SciencePharmacologyIsochrysis galbanaOintmentsMGDGMiceDrug DiscoveryMicroalgaelcsh:QH301-705.5Pharmacology Toxicology and Pharmaceutics (miscellaneous)Skinintegumentary systembiologyChemistrymicroalgaeHaptophytaHyperplasiaepidermal hyperplasiaCytokineIsochrysis galbanaCytokinesTetradecanoylphorbol AcetateFemalemedicine.drugskinglycolipids; <b>MGDG</b>; skin; inflammation; epidermal hyperplasia; microalgae; <i>Isochrysis galbana</i>Cell SurvivalDrug CompoundingSkin AbsorptionSkin DiseasesArticle03 medical and health sciencesGlycolipidIn vivoPsoriasismedicineAnimalsHumansDexamethasoneInflammationHyperplasiamedicine.diseasebiology.organism_classificationEpidermal hyperplasia030104 developmental biologylcsh:Biology (General)inflammationGlycolipidsEx vivoMarine Drugs
researchProduct

Genetic ablation of mast cells redefines the role of mast cells in skin wound healing and bleomycin-induced fibrosis.

2014

Conclusive evidence for the impact of mast cells (MCs) in skin repair is still lacking. Studies in mice examining the role of MC function in the physiology and pathology of skin regenerative processes have obtained contradictory results. To clarify the specific role of MCs in regenerative conditions, here we used a recently developed genetic mouse model that allows conditional MC ablation to examine MC-specific functions in skin. This mouse model is based on the cell type–specific expression of Cre recombinase in connective tissue–type MCs under control of the Mcpt5 promoter and the Cre-inducible diphtheria toxin receptor–mediated cell lineage ablation by diphtheria toxin. In response to ex…

KeratinocytesPathologymedicine.medical_specialtymedicine.medical_treatmentCellCre recombinaseMice TransgenicDermatologyBiologyBleomycinBiochemistrySkin Diseaseschemistry.chemical_compoundBleomycinMiceFibrosismedicineLeukocytesAnimalsMast CellsMolecular BiologyDiphtheria toxinSkin repairWound HealingAntibiotics AntineoplasticGranulation tissueCell BiologyAblationmedicine.diseaseFibrosisDisease Models Animalmedicine.anatomical_structurechemistryGranulation TissueThe Journal of investigative dermatology
researchProduct

Synergistic effect between amoxicillin and TLR ligands on dendritic cells from amoxicillin-delayed allergic patients.

2013

Journal Article; Amoxicillin, a low-molecular-weight compound, is able to interact with dendritic cells inducing semi-maturation in vitro. Specific antigens and TLR ligands can synergistically interact with dendritic cells (DC), leading to complete maturation and more efficient T-cell stimulation. The aim of the study was to evaluate the synergistic effect of amoxicillin and the TLR2, 4 and 7/8 agonists (PAM, LPS and R848, respectively) in TLR expression, DC maturation and specific T-cell response in patients with delayed-type hypersensitivity (DTH) reactions to amoxicillin. Monocyte-derived DC from 15 patients with DTH to amoxicillin and 15 controls were cultured with amoxicillin in the pr…

MaleCélulas dendríticasmedicine.medical_treatmentLymphocyte proliferationPharmacology:Chemicals and Drugs::Chemical Actions and Uses::Specialty Uses of Chemicals::Laboratory Chemicals::Ligands [Medical Subject Headings]Monocytes:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]:Phenomena and Processes::Physiological Phenomena::Pharmacological Phenomena::Pharmacological Processes::Drug Interactions::Drug Synergism [Medical Subject Headings]Cells CulturedAmoxicilinaMultidisciplinarymedicine.diagnostic_testChemistryQRLinfocitosImidazolesCitocinasMiddle AgedHumanosCytokineMedicineCytokinesFemaleDrug EruptionsResearch Article:Diseases::Skin and Connective Tissue Diseases::Skin Diseases::Exanthema [Medical Subject Headings]AdultSinergismo medicamentosoScienceFlow cytometryHipersensibilidad retardada:Chemicals and Drugs::Organic Chemicals::Amides::Lactams::beta-Lactams::Penicillins::Penicillin G::Ampicillin::Amoxicillin [Medical Subject Headings]Immune systemAntigen:Diseases::Immune System Diseases::Hypersensitivity::Hypersensitivity Delayed [Medical Subject Headings]ExantemamedicineHypersensitivity:Anatomy::Cells::Blood Cells::Leukocytes::Leukocytes Mononuclear::Lymphocytes [Medical Subject Headings]HumansLigandos:Chemicals and Drugs::Amino Acids Peptides and Proteins::Peptides::Intercellular Signaling Peptides and Proteins::Cytokines [Medical Subject Headings]:Anatomy::Cells::Antigen-Presenting Cells::Dendritic Cells [Medical Subject Headings]TLR9AmoxicillinTLR7Dendritic CellsToll-Like Receptor 2TLR2ImmunologyPloS one
researchProduct

Knowledge, stigma, health seeking behaviour and its determinants among patients with post kalaazar dermal leishmaniasis, Bihar, India

2018

Background Lesishmaniasis is a neglected tropical disease endemic in Bihar, India. Inappropriate health seeking behaviour of post kala-azar dermal leishmaniasis (PKDL) patients may increase the disease duration, severity and transmissibility. Simultaneously, lack of knowledge and perceived stigma may also increase the length of delay in receiving treatment. This ultimately effects the kala-azar elimination program. Methods A cross sectional study was conducted in 120 confirmed PKDL patients, aged 18 years and older. Data related to knowledge and health seeking behaviour was collected by a pre-tested questionnaire. EMIC stigma scale was used for assessing the perceived stigma. Patients were …

MaleHealth Knowledge Attitudes PracticePediatricsTime FactorsSocial stigmaCross-sectional studyHealth Care ProvidersHealth BehaviorSocial Stigmalcsh:MedicineDiseaseDisease VectorsPathology and Laboratory Medicine0302 clinical medicineInformed consentZoonosesMedicine and Health SciencesMedicinePublic and Occupational Health030212 general & internal medicineYoung adultlcsh:ScienceLeishmaniasisMultidisciplinaryMiddle AgedInfectious DiseasesLeishmaniasis VisceralFemaleBehavioral and Social Aspects of HealthResearch ArticleNeglected Tropical DiseasesAdultmedicine.medical_specialtyAdolescentPatients030231 tropical medicineAntiprotozoal AgentsIndiaLeishmaniasis CutaneousStigma (botany)DermatologySkin DiseasesYoung AdultKala-Azar03 medical and health sciencesSigns and SymptomsDiagnostic Medicineparasitic diseasesParasitic DiseasesHumansAgedProtozoan Infectionsbusiness.industrylcsh:RBiology and Life SciencesTropical diseasePatient Acceptance of Health CareTropical Diseasesmedicine.diseaseInsect VectorsSand FliesHealth CareSpecies InteractionsCross-Sectional StudiesLesionslcsh:QbusinessLeishmania donovaniPatient educationPLOS ONE
researchProduct